

£ 264.00
HArmonyCa With Lidocaine (2 × 1.25 mL) is a hybrid injectable dermal filler developed by Allergan Aesthetics that combines cross-linked hyaluronic acid (HA) with calcium hydroxyapatite (CaHA) microspheres. The formulation is designed to provide both immediate volumisation and longer-term collagen stimulation, positioning it within the category of hybrid biostimulatory fillers.
Unlike traditional HA fillers that focus primarily on volumisation, HArmonyCa With Lidocaine integrates CaHA technology to support dermal structure and stimulate neocollagenesis while simultaneously restoring facial contours. The product is intended for deep dermal and subcutaneous implantation in facial areas affected by volume loss, reduced elasticity, and skin laxity.
What HArmonyCa™ With Lidocaine Is Similar ToHArmonyCa can be regarded alongside other collagen-stimulating injectables such as calcium hydroxyapatite fillers and hybrid biostimulatory dermal fillers. Compared with standard hyaluronic acid fillers, it combines an immediate lifting effect from HA with longer-term tissue support associated with CaHA-induced collagen stimulation.
In aesthetic practice, hybrid fillers are often selected for patients seeking both contour restoration and progressive skin quality improvement. Unlike products designed solely for wrinkle filling, HArmonyCa focuses on structural support, dermal density enhancement, and skin tightening. This comparison is provided for clinical orientation only and does not imply interchangeability.
Treatment Areas / IndicationsAccording to manufacturer documentation, HArmonyCa With Lidocaine is indicated for soft tissue augmentation and correction of facial volume loss.
Treatment areas may include:
Midface • Cheeks • Jawline • Lower face • Areas affected by skin laxity and reduced elasticity
→ Intended for deep dermal and subcutaneous placement depending on practitioner assessment.
Usage / Administration (IFU-only)Injection depth: Deep dermal and subcutaneous layers.
Volume per point / injection site: Not publicly specified by manufacturer.
Needle specification: 27G needles supplied with product packaging.
Frequency / number of sessions: Treatment schedule should follow official IFU guidance and practitioner assessment.
Professional-use disclaimer: Administered only by qualified medical professionals under aseptic conditions.
If any parameter is omitted in the official IFU, it is marked as “not provided by manufacturer.”
Ingredient ListCross-linked sodium hyaluronate: 20 mg/mL
Calcium hydroxyapatite microspheres: 55.7% concentration
Lidocaine hydrochloride: 3 mg/mL
Phosphate buffer solution
Sterile water for injection
Other excipients as per IFU.
Presentation & LongevityPresentation: 2 × 1.25 mL pre-filled sterile syringes with 27G needles included.
Shelf-life: Refer to packaging for expiry date.
Longevity (treatment duration): Clinical discussions and distributor documentation suggest prolonged results associated with collagen stimulation; duration varies according to patient factors and treatment protocol.
Safety Notes / ContraindicationsUse is contraindicated in patients with known hypersensitivity to hyaluronic acid, lidocaine, calcium hydroxyapatite, or any component of the formulation.
Avoid use in patients with active infection, inflammation, or dermatological conditions at the treatment site.
Do not inject intravascularly.
Proper anatomical knowledge and advanced injection technique are essential due to deep placement requirements.
Single use only; ensure packaging is intact and within expiry.
Regulatory StatusCE-marked medical device in Europe.
UKCA status: verify via IFU or authorised distributor.
Regulatory classification may vary by jurisdiction; confirm on packaging or manufacturer documentation.
1. What is HArmonyCa With Lidocaine used for?
HArmonyCa With Lidocaine is used for facial soft tissue augmentation, contour restoration, and collagen stimulation in areas affected by ageing and volume loss.
2. How is HArmonyCa different from traditional HA fillers?
Unlike standard hyaluronic acid fillers, HArmonyCa combines HA with calcium hydroxyapatite microspheres to provide both immediate volume and longer-term collagen stimulation.
3. Does HArmonyCa contain lidocaine?
Yes. The formulation contains lidocaine hydrochloride to support patient comfort during treatment.
4. Where is HArmonyCa injected?
It is intended for deep dermal and subcutaneous implantation in facial areas such as the cheeks, jawline, and lower face.
5. What makes HArmonyCa a hybrid filler?
The product combines cross-linked hyaluronic acid with calcium hydroxyapatite microspheres, providing both immediate volumisation and progressive collagen support.
Compare insurance quotes from trusted partners.
255 products
6,106 sold